Chemoinformaics analysis of 2-Vinyl-4H-1,3-dithiine
Molecular Weight | 144.264 | nRot | 1 |
Heavy Atom Molecular Weight | 136.2 | nRig | 1 |
Exact Molecular Weight | 144.007 | nRing | 1 |
Solubility: LogS | -5.736 | nHRing | 1 |
Solubility: LogP | 5.764 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 21.1543 |
nHD | 0 | BPOL | 12.9457 |
QED | 0.361 |
Synth | 1.82 |
Natural Product Likeliness | 0.924 |
NR-PPAR-gamma | 0.032 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.015 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.49 |
MDCK | 0.0000159 |
BBB | 0.98 |
PPB | 0.968847 |
VDSS | 1.367 |
FU | 0.0354428 |
CYP1A2-inh | 0.936 |
CYP1A2-sub | 0.411 |
CYP2c19-inh | 0.62 |
CYP2c19-sub | 0.339 |
CYP2c9-inh | 0.377 |
CYP2c9-sub | 0.91 |
CYP2d6-inh | 0.118 |
CYP2d6-sub | 0.595 |
CYP3a4-inh | 0.475 |
CYP3a4-sub | 0.118 |
CL | 5.219 |
T12 | 0.224 |
hERG | 0.045 |
Ames | 0.014 |
ROA | 0.039 |
SkinSen | 0.949 |
Carcinogencity | 0.107 |
EI | 0.985 |
Respiratory | 0.361 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.941861 |